Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Vascular targeting--a new approach to the therapy of solid tumors.

Burrows FJ, Thorpe PE.

Pharmacol Ther. 1994 Oct;64(1):155-74. Review.

PMID:
7846113
[PubMed - indexed for MEDLINE]
2.

Antibody-directed targeting of the vasculature of solid tumors.

Thorpe PE, Burrows FJ.

Breast Cancer Res Treat. 1995;36(2):237-51. Review.

PMID:
8534871
[PubMed - indexed for MEDLINE]
3.

Recent progress on tumor missile therapy and tumor vascular targeting therapy as a new approach.

Yoshioka Y, Tsutsumi Y, Nakagawa S, Mayumi T.

Curr Vasc Pharmacol. 2004 Jul;2(3):259-70. Review.

PMID:
15320824
[PubMed - indexed for MEDLINE]
4.

Vascular endothelial growth factor as a marker of tumor endothelium.

Brekken RA, Huang X, King SW, Thorpe PE.

Cancer Res. 1998 May 1;58(9):1952-9.

PMID:
9581838
[PubMed - indexed for MEDLINE]
Free Article
5.

A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors.

Burrows FJ, Watanabe Y, Thorpe PE.

Cancer Res. 1992 Nov 1;52(21):5954-62.

PMID:
1394221
[PubMed - indexed for MEDLINE]
Free Article
6.

Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies.

Dvorak HF, Nagy JA, Dvorak AM.

Cancer Cells. 1991 Mar;3(3):77-85. Review.

PMID:
1711364
[PubMed - indexed for MEDLINE]
7.

Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.

Burrows FJ, Thorpe PE.

Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8996-9000.

PMID:
7692443
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Potent antitumor effects of an antitumor endothelial cell immunotoxin in a murine vascular targeting model.

Burrows FJ, Overholser JP, Thorpe PE.

Cell Biophys. 1994;24-25:15-25.

PMID:
7736519
[PubMed - indexed for MEDLINE]
9.

Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.

Seon BK, Matsuno F, Haruta Y, Kondo M, Barcos M.

Clin Cancer Res. 1997 Jul;3(7):1031-44.

PMID:
9815781
[PubMed - indexed for MEDLINE]
Free Article
10.

Vascular endothelial growth factor and vascular targeting of solid tumors.

Brekken RA, Thorpe PE.

Anticancer Res. 2001 Nov-Dec;21(6B):4221-9. Review.

PMID:
11908675
[PubMed - indexed for MEDLINE]
11.

Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.

Matsuno F, Haruta Y, Kondo M, Tsai H, Barcos M, Seon BK.

Clin Cancer Res. 1999 Feb;5(2):371-82.

PMID:
10037187
[PubMed - indexed for MEDLINE]
Free Article
12.

Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor--immunotoxin target gene.

Jin N, Chen W, Blazar BR, Ramakrishnan S, Vallera DA.

Hum Gene Ther. 2002 Mar 1;13(4):497-508.

PMID:
11874628
[PubMed - indexed for MEDLINE]
13.

Antibody-based targeting of the tumor vasculature.

Schliemann C, Neri D.

Biochim Biophys Acta. 2007 Dec;1776(2):175-92. Epub 2007 Aug 25. Review.

PMID:
17920773
[PubMed - indexed for MEDLINE]
Free Article
14.

Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats.

Ohizumi I, Tsunoda S, Taniguchi K, Saito H, Esaki K, Makimoto H, Wakai Y, Tsutsumi Y, Nakagawa S, Utoguchi N, Kaiho S, Ohsugi Y, Mayumi T.

Biochem Biophys Res Commun. 1997 Jul 18;236(2):493-6.

PMID:
9240467
[PubMed - indexed for MEDLINE]
15.

VEGF-VEGF receptor complexes as markers of tumor vascular endothelium.

Brekken RA, Thorpe PE.

J Control Release. 2001 Jul 6;74(1-3):173-81. Review.

PMID:
11489493
[PubMed - indexed for MEDLINE]
16.

[Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].

Chiron MF.

Bull Cancer. 1997 Dec;84(12):1135-40. Review. French.

PMID:
9587366
[PubMed - indexed for MEDLINE]
17.

Immunoconjugates and immunotoxins for therapy of solid tumors.

Hellström I, Trail P, Siegall C, Firestone R, Hellström KE.

Cancer Chemother Pharmacol. 1996;38 Suppl:S35-6. Review. No abstract available.

PMID:
8765413
[PubMed - indexed for MEDLINE]
18.

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins.

Halin C, Niesner U, Villani ME, Zardi L, Neri D.

Int J Cancer. 2002 Nov 10;102(2):109-16.

PMID:
12385005
[PubMed - indexed for MEDLINE]
19.

VEGF as a mediator of tumor-associated immunodeficiency.

Ohm JE, Carbone DP.

Immunol Res. 2001;23(2-3):263-72. Review.

PMID:
11444391
[PubMed - indexed for MEDLINE]
20.

Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy?

Denekamp J, Daşu A, Waites A.

Adv Enzyme Regul. 1998;38:281-99.

PMID:
9762359
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk